Bcl-2-IN-14

CAT:

804-HY-149624

Size:

Inquire

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: Bcl-2-IN-14 (Compound 13c) is a BCL-2 inhibitor with an IC50 value of 0.471 μM. Bcl-2-IN-14 can be used in cancer research[1].
Target Antigen: Bcl-2 Family
Type: Reference compound
Related Pathways: Apoptosis
Applications: Cancer-programmed cell death
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/bcl-2-in-14.html
Solubility: 10 mM in DMSO
Smiles: O=C(C1=CC(SC(NC(C2=CC=C(NCCC3=CC=CC=C3)C([N+]([O-])=O)=C2)=O)=N4)=C4C=C1)NC5=CC=C(C=C5)OCC6=CC=C(C)C=C6
Molecular Weight: 657.74
References & Citations: [1]Ismail HS, et al. Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors. Sci Rep. 2023 Sep 20;13(1):15554.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported

Cat	Name
MBS5824562	Bcl-2-IN-14
T39961-50mg	Bcl-2-IN-2
T39961-1mg	Bcl-2-IN-2
T39961-5mg	Bcl-2-IN-2
T39961-10mg	Bcl-2-IN-2
T39961-1g	Bcl-2-IN-2
MBS5800327	Bcl-2-IN-2
MBS655267-02	Bcl G (Bcl-2-like 14) (Control Peptide)
MBS655267-01	Bcl G (Bcl-2-like 14) (Control Peptide)
T63521-50mg	Bcl-2-IN-7